LAMIVUDINE
NDC 60505-3251, lamivudine, tablet, film coated, from Apotex Corp..
- Product NDC
- 60505-3251
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091606
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMIVUDINE150 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-3251-6 | 60505325106 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-3251-6) |
| 60505-3251-8 | 60505325108 | 1000 TABLET, FILM COATED in 1 BOTTLE (60505-3251-8) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/34c02bcc-d6ff-99d4-8e6a-4a91908adca8NADAC price for package 60505325106
GET /v1/drugs/nadac/60505325106
Use it
Look up 60505-3251 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-3251. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.